SIGMA HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.255 AUD | +0.40% |
|
-3.46% | +24.88% |
| 06-13 | Global markets live: Shell, Broadcom, Apple, Sony, Apple... |  |
| 06-13 | Australian Shares Rebound as Unemployment Rate Eases | MT |
Valuation
| Fiscal Period: January | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 583.4 | 651.3 | 444.9 | 629.2 | 1,622 | 1,963 | - | - |
| Enterprise Value (EV) 1 | 779.3 | 701.6 | 594.1 | 696.2 | 1,265 | 2,485 | 2,507 | 2,496 |
| P/E ratio | -46.2 x | 11.2 x | -64.3 x | 318 x | 259 x | 29.8 x | 25 x | 22.3 x |
| Yield | 1.67% | 1.52% | 4.44% | 2.36% | 0.97% | 2.72% | 3.2% | 3.6% |
| Capitalization / Revenue | 0.18 x | 0.19 x | 0.13 x | 0.17 x | 0.49 x | 0.31 x | 0.29 x | 0.27 x |
| EV / Revenue | 0.24 x | 0.21 x | 0.17 x | 0.19 x | 0.38 x | 0.39 x | 0.37 x | 0.35 x |
| EV / EBITDA | 16.7 x | 8.44 x | 7.89 x | 12.3 x | 21.2 x | 2.98 x | 2.64 x | 2.37 x |
| EV / FCF | 5.43 x | -10.9 x | -9.82 x | 6.14 x | 34 x | 5.33 x | 5.72 x | 4.67 x |
| FCF Yield | 18.4% | -9.2% | -10.2% | 16.3% | 2.94% | 18.8% | 17.5% | 21.4% |
| Price to Book | 1.23 x | 1.22 x | 1.13 x | 1.65 x | 1.95 x | 13.9 x | 12.5 x | - |
| Nbr of stocks (in thousands) | 972,253 | 986,821 | 988,667 | 990,820 | 1,567,112 | 1,570,572 | - | - |
| Reference price 2 | 0.6000 | 0.6600 | 0.4500 | 0.6350 | 1.035 | 1.250 | 1.250 | 1.250 |
| Announcement Date | 3/24/20 | 3/22/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: January | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,244 | 3,400 | 3,446 | 3,660 | 3,322 | 6,394 | 6,833 | 7,163 |
| EBITDA 1 | 46.71 | 83.16 | 75.28 | 56.6 | 59.7 | 833.5 | 949 | 1,051 |
| EBIT 1 | 30.44 | 52.17 | 47.59 | 26.26 | 31.4 | 761.7 | 871.6 | 972.3 |
| Operating Margin | 0.94% | 1.53% | 1.38% | 0.72% | 0.95% | 11.91% | 12.76% | 13.57% |
| Earnings before Tax (EBT) | -15.76 | 51.7 | -8.307 | 5.462 | 8.6 | - | - | - |
| Net income 1 | -12.33 | 59.76 | -7.239 | 1.8 | 4.5 | 484.8 | 573.2 | 652.5 |
| Net margin | -0.38% | 1.76% | -0.21% | 0.05% | 0.14% | 7.58% | 8.39% | 9.11% |
| EPS 2 | -0.0130 | 0.0590 | -0.007000 | 0.002000 | 0.004000 | 0.0420 | 0.0500 | 0.0560 |
| Free Cash Flow 1 | 143.5 | -64.56 | -60.48 | 113.3 | 37.25 | 466.1 | 438.3 | 534.7 |
| FCF margin | 4.42% | -1.9% | -1.76% | 3.1% | 1.12% | 7.29% | 6.41% | 7.46% |
| FCF Conversion (EBITDA) | 307.17% | - | - | 200.26% | 62.39% | 55.92% | 46.19% | 50.88% |
| FCF Conversion (Net income) | - | - | - | 6,296.61% | 827.71% | 96.14% | 76.47% | 81.95% |
| Dividend per Share 2 | 0.0100 | 0.0100 | 0.0200 | 0.0150 | 0.0100 | 0.0340 | 0.0400 | 0.0450 |
| Announcement Date | 3/24/20 | 3/22/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: January | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,642 | - | 1,733 | 1,714 | - | 1,824 | 1,682 | 1,640 |
| EBITDA 1 | 14.79 | 34.14 | - | 39.8 | - | 28.59 | 28.01 | 36.72 | 22.98 |
| EBIT 1 | 6.463 | 19.6 | - | 26.46 | - | 13.31 | 12.95 | 22.39 | 9.006 |
| Operating Margin | - | 1.19% | - | 1.53% | - | - | 0.71% | 1.33% | 0.55% |
| Earnings before Tax (EBT) | - | - | - | -0.736 | - | -0.94 | 6.402 | 14.06 | - |
| Net income 1 | -14.85 | 4.711 | - | -1.3 | - | -1.49 | 3.29 | 11.23 | -6.729 |
| Net margin | - | 0.29% | - | -0.08% | - | - | 0.18% | 0.67% | -0.41% |
| EPS | - | - | - | -0.001000 | - | -0.002000 | 0.004000 | 0.0110 | - |
| Dividend per Share 2 | - | 0.0100 | 0.0100 | 0.0100 | - | 0.005000 | 0.0100 | 0.005000 | 0.005000 |
| Announcement Date | 3/24/20 | 9/9/20 | 3/22/21 | 9/20/21 | 3/28/22 | 9/25/22 | 3/22/23 | 9/19/23 | 3/20/24 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: January | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 196 | 50.3 | 149 | 67 | - | 522 | 544 | 533 |
| Net Cash position 1 | - | - | - | - | 357 | - | - | - |
| Leverage (Debt/EBITDA) | 4.196 x | 0.6049 x | 1.982 x | 1.184 x | - | 0.6262 x | 0.5729 x | 0.5067 x |
| Free Cash Flow 1 | 143 | -64.6 | -60.5 | 113 | 37.2 | 466 | 438 | 535 |
| ROE (net income / shareholders' equity) | 2.55% | 5.76% | 5.65% | 0.38% | 0.67% | 47.1% | 50.1% | 51.1% |
| ROA (Net income/ Total Assets) | 0.97% | 2.41% | 2.32% | 0.15% | 0.35% | 11.6% | 13.8% | 15.1% |
| Assets 1 | -1,269 | 2,484 | -311.5 | 1,204 | 1,276 | 4,179 | 4,154 | 4,321 |
| Book Value Per Share 2 | 0.4900 | 0.5400 | 0.4000 | 0.3900 | 0.5300 | 0.0900 | 0.1000 | - |
| Cash Flow per Share | - | 0.0100 | -0.0500 | 0.1400 | 0.0400 | - | - | - |
| Capex 1 | 57.1 | 77 | 14.2 | 29.4 | 4.72 | 23.5 | 25.3 | 27 |
| Capex / Sales | 1.76% | 2.27% | 0.41% | 0.8% | 0.14% | 0.37% | 0.37% | 0.38% |
| Announcement Date | 3/24/20 | 3/22/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
1.25
AUD
Average target price
1.105
AUD
Spread / Average Target
-11.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.88% | 1.31B | |
| +29.50% | 77.77B | |
| +0.30% | 24.62B | |
| +14.70% | 8.75B | |
| +0.49% | 8.35B | |
| -28.87% | 7.1B | |
| +15.51% | 5.25B | |
| +1.86% | 4.1B | |
| -8.90% | 3.8B | |
| -7.62% | 3.39B |
- Stock Market
- Equities
- SIG Stock
- Financials Sigma Healthcare Limited
